Both in Pharmaceuticals
Gain Therapeutics vs Annovis Bio
Over the past year GANX returned −42.3% and ANVS returned −46.2%; their daily moves had a correlation of 0.20.
GANX −42.3% ANVS −46.2%Growth of $1, one year, split-adjusted
| Metric | GANX | ANVS |
|---|---|---|
| Price | $1.13 | $1.13 |
| Market cap | $49.3M | $48.2M |
| Today | −5.04% | +10.78% |
| 1 month | −34.3% | −3.4% |
| 6 months | −39.9% | −43.5% |
| Year to date | −64.9% | −67.3% |
| 1 year | −37.9% | −48.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $12.7M | $18.7M |
| Dividend yield | — | — |
| Volatility (60d) | 64.4% | 75.6% |
| Short % of float | 7.6% | 15.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).